{"id":605956,"date":"2026-04-14T09:29:30","date_gmt":"2026-04-14T09:29:30","guid":{"rendered":"https:\/\/www.newsbeep.com\/au\/605956\/"},"modified":"2026-04-14T09:29:30","modified_gmt":"2026-04-14T09:29:30","slug":"why-this-asx-healthcare-stock-is-surging-while-the-market-sinks-on-middle-east-fears","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/au\/605956\/","title":{"rendered":"Why this ASX healthcare stock is surging while the market sinks on Middle East fears"},"content":{"rendered":"

The\u00a0Avita Medical Inc\u00a0(ASX: AVH<\/a>) share price is pushing higher again on Friday, extending its strong short-term rebound.<\/p>\n

In afternoon trade, the Avita share price has shot up 8.33% to $1.30, taking its 1 week gain to almost 20%.<\/p>\n

That surge is standing out against a weaker backdrop, with the\u00a0S&P\/ASX All Ordinaries Index\u00a0(ASX: XAO) down 0.3% to 9,138 points. This comes as investors react to the latest developments in the Middle East between the US, Israel and Iran.<\/p>\n

Fortunately for Avita, the rebound has been building for several sessions this week. The stock rose 6.31% on Wednesday and added another 1.69% on Thursday, despite widespread selling across the ASX.<\/p>\n

Let’s take a look at what’s driving the shares higher.<\/p>\n

\"Woman<\/p>\n

Image source: Getty Images<\/p>\n

Major US government deal supports sentiment<\/p>\n

Avita’s\u00a0update<\/a>\u00a0this week appears to be the key catalyst, centred on a 10-year agreement with the US Biomedical Advanced Research and Development Authority (BARDA).<\/p>\n

Worth up to US$25.5 million, the deal is aimed at strengthening US emergency preparedness for large-scale burn casualty events.<\/p>\n

BARDA will have access to 3,000 units of Avita’s RECELL treatment platform at any point during the contract period. Avita will also manage inventory, logistics support, and deployment readiness.<\/p>\n

The full contract value includes procurement options that may not all be exercised. Avita said about US$3.97 million is expected to flow through as revenue over the 10-year term via annual access and readiness support fees.<\/p>\n

The market is repricing execution risk<\/p>\n

Friday’s rally is also notable because it comes after a prolonged period of heavy selling in the stock.<\/p>\n

Even with this week’s rebound, Avita shares remain down more than 50% over the past 12 months. This shows how aggressively the market had already marked down execution risk and earnings uncertainty.<\/p>\n

Foolish takeaway<\/p>\n

Avita’s sharp rebound this week shows how quickly sentiment can turn when a beaten-down small-cap healthcare stock lands a credible long-term government contract.<\/p>\n

The BARDA update clearly improves revenue visibility and gives the market a stronger reason to revisit the recovery outlook.<\/p>\n

That said, it is still a small-cap healthcare stock with elevated execution risk, and this week’s rally does not change the fact that the shares remain down over the past year.<\/p>\n

Personally, this is not the type of stock I would be chasing after a sharp short-term move. I would rather put my money into larger, more established businesses with steadier earnings and less share price\u00a0volatility<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"The\u00a0Avita Medical Inc\u00a0(ASX: AVH) share price is pushing higher again on Friday, extending its strong short-term rebound. In…\n","protected":false},"author":2,"featured_media":605957,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[34],"tags":[64,63,137,500],"class_list":{"0":"post-605956","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-healthcare","8":"tag-au","9":"tag-australia","10":"tag-health","11":"tag-healthcare"},"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/posts\/605956","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/comments?post=605956"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/posts\/605956\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/media\/605957"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/media?parent=605956"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/categories?post=605956"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/tags?post=605956"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}